Hemolysis Screening Services

Hemolysis testing is used to uncover potential toxicity issues early in the Drug Discovery process, while they are still easy and relatively inexpensive to address. It is also used to evaluate potential new excipients. The assay is configured in a miniaturized 96-well format that requires only small amounts of compound, appropriate for discovery-stage studies.

Contact us to learn more about Apredica's hemolysis screening services.

REFERENCES:

• "Guidance for Industry: Nonclinical Studies for the Safety Evaluation of Pharmaceutical Excipients," US FDA (
2005)